Aneurysmal versus “Benign” Perimesencephalic Subarachnoid Hemorrhage ======================================================================== * Anas Alrohimi * Mark A Davison * Abhi Pandhi * Mohammad A Abdulrazzak * Daniel Wadden * Mark Bain * Nina Moore * M. Shazam Hussain * Gabor Toth ## ABSTRACT **Introduction** The rate of underlying ruptured aneurysm, complications, and outcomes in “benign” perimesencephalic subarachnoid hemorrhage (PMSAH) are not well known and underreported. **Methods** Retrospective analysis of patients with PMSAH from a large tertiary care center (2007-2023). Clinical and imaging data were studied. **Results** Eighty-one patients were included with mean age of 55.5 ± 10.3 years. Median (IQR) Hunt and Hess grade was 2 (1-2), and modified Fisher grade was 3 (1-3). An underlying ruptured aneurysm was diagnosed in 5 patients (6.2%). The most common complication was vasospasm in 25 patients (31%) with a significantly higher rate of symptomatic vasospasm among patients with underlying aneurysm (40% vs 2.6%; P=0.01). The median (IQR) time of vasospasm detection was 7 (8-9) days. The majority of vasospasm cases (84%) were asymptomatic, which was not associated with poor outcomes (OR= 0.95, [0.22–4.1], *P*=0.9) compared to the asymptomatic vasospasm (OR= 8.6, [1.06-69.88], *P*= 0.04). Hydrocephalus occurred in 10% of patients within one day, at higher rate in the aneurysmal group (40% vs 8%; P=0.07). A total of 88% of patients had a favorable functional outcome (mRS 0-2) at discharge, but at a significantly higher rate in non-aneurysmal patients (91% vs 40%; P=0.01). An underlying aneurysm and hydrocephalus were associated with poor functional status (OR= 14.7, [2.1–104], *P*=0.007, and OR= 22.6, [4.2–123.5], *P* <0.001), respectively. **Conclusion** “Benign” PMSAH pattern was associated with a ruptured aneurysm in 6.2% of patients, which highlights the critical value of conventional cerebral angiogram in the workup. Expectedly, an underlying aneurysm was associated with higher rates of symptomatic vasospasm, hydrocephalus, and lower rates of good clinical outcome. Aneurysm and hydrocephalus were independently associated with poorer outcomes, however, these were detected very early during hospitalization. Vasospasm alone was not associated with poor outcomes. Our findings suggest that non-aneurysmal PMSAH patients can safely be managed with less strict monitoring and a shorter hospital stay. Keywords * perimesencephalic subarachnoid hemorrhage * aneurysm * vasospasm * hydrocephalus * digital subtraction angiography ## INTRODUCTION Non-traumatic subarachnoid hemorrhage is a prevalent and often devastating pathology which accounts for approximately 5% of all strokes in the United States.(1) Potential etiologies for a spontaneous subarachnoid bleed are many, and while an intracranial aneurysm is frequently the culprit, an underlying etiology is not always evident in up to 15-20% of cases.(2, 3) Benign perimesencephalic subarachnoid hemorrhage (PMSAH) was first described in 1985 as a subset of patients with SAH that was identified with a pattern of hemorrhage centered anterior to the midbrain without frank extension to the anterior interhemispheric fissure, lateral sylvian fissure intraparenchymal or intraventricular, without an identifiable vascular lesion, and a benign clinical course.(3–5) Diagnostic investigation of spontaneous subarachnoid hemorrhage often begins with computed tomography angiography (CTA), however digital subtraction angiography (DSA) remains the gold standard for identifying intracranial vascular pathology. Given that CTA technology continues to advance, some reports suggest that providers may be able to forego DSA in patients with PMSAH following a negative CTA.(6) While the yield of DSA in the PMSAH population following a negative CTA is low, the consequences of missing an occult intracranial aneurysm could be devastating. The term “benign” is often associated, because typically no source of bleeding is identified on high-resolution vascular imaging and recovery is often uncomplicated. However, PMSAH can be secondary to ruptured vertebrobasilar aneurysms in 5-7% of patients and outcomes in these patients is underreported.(5, 7) Moreover, while relatively infrequent, patients with PMSAH have been known to suffer from symptomatic hydrocephalus or vasospasm, which may confer a significant morbidity to the patient.(8) Therefore, it is essential to consider a large patient cohort while assessing the incidence of a relatively infrequent event and study clinical outcomes. We conducted a retrospective analysis of patients with PMSAH in a large single center to determine the rate of underlying ruptured aneurysm, associated complications, its timeline, outcomes, and report the diagnostic yield of DSA. ## METHODS ### Study design The current study is a retrospective analysis of PMSAH patients treated at a large single-center institution from 2007-2023. Eligible patients were identified via ENCORE radiology angiogram reports database. Specifically, reports including either the keywords (perimesencephalic, and perimesencephalic subarachnoid hemorrhage) were selected. The non-contrast CT brain scan of all identified patients were assessed to confirm an accurate radiographic diagnosis of PMSAH. CT angiogram of the brain were reviewed as well. Patients with both a diagnosis of PMSAH, available medical records and images for review were included. Age, sex, vascular risk factors (hypertension, smoking, and family history of intracranial aneurysms), clinical presentation, Hunt and Hess scale, modified Fisher grade, and rate of underlying ruptured aneurysm were collected. Vasospasm based on clinical, sonographic and angiographic diagnosis, hydrocephalus based on clinical and radiographic diagnosis, the number of patients required external ventricular drain (EVD) and discharged modified Rankin scale (mRS) were gathered. Data was analyzed for all patients, as well as the aneurysmal and non-aneurysmal groups separately for comparison. Institutional Review Boards approval was obtained. ### Imaging Procedures and Analysis All patients enrolled in the analysis had a non-contrast head computed tomography (CT), CT angiography, and digital subtraction angiography (DSA) at baseline. In the event of clinical deterioration, CT scans were repeated. In the event of clinical deterioration with sonographic diagnosis of vasospasm, DSA was repeated. All images were independently analyzed by three endovascular surgical neuroradiology fellows (AA, AP and MAA), and any disagreement was resolved by consensus. ### Outcomes The primary endpoint was good functional status at discharge, which was defined as a Modified Rankin Score (mRS) of 0-2. The incidence of an underlying ruptured aneurysm through DSA, and whether it is present in CTA, was reported. Additionally, clinical complications including the rate of hydrocephalus and vasospasm were documented. ### Statistical analysis Statistical analyses were performed using the Statistical Package for Social Sciences version 28.0.0 (IBM SPSS Statistics Inc, 2015, Armonk, NY, USA). Baseline characteristics were reported by mean and standard deviations (SD) for continuous variables with normal distribution, median and interquartile ranges (IQRs) for continuous variables with skewed distribution, frequency and percentage for categorical variables. Differences between groups were assessed using independent t-tests for parametric data, and Mann-Whitney-U tests for non-parametric data. The distribution of outcomes was assessed with Pearson’s χ2 test or Fisher’s exact test. Univariable and Multivariable (if required) logistic regression models were used to determine factors that are independently associated with ruptured aneurysm and outcomes. Functional outcome at discharge was dichotomized as independent (mRS score 0-2) and dependent (mRS score 3-6). ## RESULTS ### Patient characteristics A total of 86 patients identified between 2007 and 2023 were assessed for eligibility. Of these, 81 patients met the criteria and were included in the analysis. An underlying ruptured aneurysm was found in 5 patients (6.2%); four of which were in the vertebrobasilar system and one in the posterior communicating artery. Baseline characteristics of patients with and without underlying aneurysm is summarized in **Table 1**. Mean patient age was 55.5 ± 10.3 years and 62% were male. Among vascular risk factors, hypertension and smoking were reported in 55% and 35% of all patients, respectively. Only one patient reported family history of ruptured intracranial aneurysm, in the non-aneurysmal PMSAH group. With regards to the presenting symptoms, the most common symptom was thunderclap headache in 89% of patients. Cranial neuropathy and extremity weakness were reported in 6% and 4%, respectively. Median (IQR) of Glasgow coma scale was 15 (15-15). Median (IQR) of Hunt and Hess scale was 2 (1-2), and modified Fisher grade was 3 (1-3). View this table: [Table 1.](http://medrxiv.org/content/early/2023/07/23/2023.07.17.23292803/T1) Table 1. Baseline patients’ characteristics ### PMSAH workup and patient outcomes An underlying ruptured aneurysm was found in 5 patients (6.2%); three of which (60%) were detected in DSA (two on initial DSA and one on follow-up DSA), and the median (IQR) time of aneurysmal detection was 1 (1-2) day. Smoking (*P*=0.04), Hunt and Hess scale (*P*=0.04), and modified Fisher grade (*P*=0.01) were significantly higher in patients with aneurysmal PMSAH. A total of 71 (88%) patients in this cohort had a repeat diagnostic angiogram. The most common complication in the whole cohort was vasospasm in 25 (31%) patients; the majority of which (84%) were asymptomatic. Among the aneurysmal PMSAH group, symptomatic vasospasm was detected in 2 out of 5 patients (40%) which was significantly higher than the non-aneurysmal PMSAH group (2 out of 76 patients, 2.6%; *P*= 0.01). All 4 patients with symptomatic vasospasm received intra-arterial vasodilation therapy, and two received additional angioplasty. The median (IQR) time of all vasospasm detection was 7 (8-9) days, and asymptomatic vasospasm was not associated with unfavourable outcomes (OR= 0.95, [0.22–4.1], *P*= 0.9). However, symptomatic vasospasm was associated with worse outcomes (OR= 8.6, [1.06-69.88], *P*= 0.04). Acute hydrocephalus occurred in overall 10% of patients, at a numerically higher rate in the aneurysmal group, however, the difference was not statistically significant (40% vs 8%; *P*= 0.07). All hydrocephalus cases were symptomatic, and occurred within 1 day, but at a significantly higher rate in the aneurysmal group (2 out of 5 patients, 40%). In the entire cohort, median (IQR) of mRS at discharge was 0 (0-1), and a total of 71 (88%) patients had a favorable functional outcome (mRS 0-2) at discharge. The median (IQR) mRS at discharge of patients with aneurysmal PMSAH pattern was 3 (1-4) which was not significantly higher than the non-aneurysmal group 0 (0-1); *P*=0.07. However, the distribution of mRS between the two groups was significantly different, *P*= 0.015. The favorable functional outcome (mRS 0-2) at discharge in the aneurysmal PMSAH pattern group (40%) was significantly lower than the non-aneurysmal group (91%); *P*=0.01. In our analysis, an underlying ruptured aneurysm and acute hydrocephalus were associated with poor functional status (OR= 14.7, [2.1–104], P=0.007; Figure 1), and OR= 22.6, [4.2–123.5], P <0.001), respectively. ![Figure 1.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2023/07/23/2023.07.17.23292803/F1.medium.gif) [Figure 1.](http://medrxiv.org/content/early/2023/07/23/2023.07.17.23292803/F1) Figure 1. Functional status at discharge of patients with aneurysmal and non-aneurysmal source of PMSAH. ## DISCUSSION In this retrospective analysis of 81 patients with PMSAH, the rate of underlying ruptured aneurysm through catheter angiography was 6.2%. All aneurysms were found in the posterior circulation. The presence of an underlying ruptured aneurysm was associated with worse clinical outcomes, and higher rates of symptomatic vasospasm and hydrocephalus. The low but non-negligible rate and serious clinical consequences highlight the sustained critical value of conventional cerebral angiogram in the diagnostic workup of PMSAH. On the other hand, the low rates of symptomatic hydrocephalus and vasospasm, and early appearance of acute hydrocephalus in the non-aneurysmal PMSAH group provide clinical evidence for less strict clinical monitoring, earlier discharge and decreased length of hospitalization for these patients. The current study is one of the largest published cohorts of patients with PMSAH to date, and is the largest series which has included patients within the last decade. Our extensive literature review resulted in 16 studies including over 650 patients with PMSAH pattern on conventional CT brain and a negative CTA. Diagnostic cerebral angiography was found to be positive for an occult aneurysm in approximately 3.2 – 3.5% of patients (**Table 3**). While our finding of a 6.2% aneurysm identification rate was slightly higher, these findings are clinically significant when considering the devastating consequences of missing an occult ruptured aneurysm: re-rupture rates are known to reach 50% in 6 months, with the highest risk occurring in the first 48 hours.(2, 9) Interestingly, the vast majority (approximately 81% in the literature and 60% in our cohort) of aneurysms identified on DSA who had negative CTA were in the vertebrobasilar circulation, which could be related to increased bone artifact from the posterior fossa. View this table: [Table 2.](http://medrxiv.org/content/early/2023/07/23/2023.07.17.23292803/T2) Table 2. Patients’ outcomes View this table: [Table 3.](http://medrxiv.org/content/early/2023/07/23/2023.07.17.23292803/T3) Table 3. Diagnostic yield of digital subtraction angiography in the PMSAH population; the current study and summary of the literature. In contrast to classic aneurysmal SAH, the majority of patients with benign PMSAH pattern were male (62%) with a mean age of 55.5 years. This demographic finding in our population is consistent with prior reports.(5, 10) The higher rate of hypertension and smoking, though the former was not significant, in the aneurysmal PMSAH group is not surprising, and confirms the relevance of these vascular risk factors in aneurysm formation and rupture.(11) Compared to classic aneurysmal SAH, patients with PMSAH tend to present with milder symptoms with lower Hunt and Hess scale and modified Fisher grade, which was also demonstrated in our cohort.(5) This finding suggests that an underlying ruptured aneurysm should be considered and searched for when interpreting vascular imaging of patients with a more severe clinical profile, and one should not hesitate to obtain a conventional angiogram for these patients. Complications such as vasospasm and hydrocephalus were reported previously to be infrequent after PMSAH compared to aneurysmal SAH.(5) While radiographic vasospasm was observed in overall 31% in our cohort, only 4 patients of the cohort (4.9%) were symptomatic; 2 (40%) in the aneurysmal and 2 (2.6%) in the non-aneurysmal group. The median time of all vasospasm detection was 7 (8-9) days. Our results confirm that symptomatic vasospasm in non-aneurysmal PMSAH patients is a rare phenomenon, only described previously in case reports or small patient series. However, vasospasm, even if present, was not associated with worse outcome in our cohort. Contrary to the historical belief about benign PMSAH, acute hydrocephalus can occur in this group as was seen in 8% of our non-aneurysmal PMSAH population, which was still much lower than the aneurysmal group (40%). All cases occurred within 1 day, suggesting the hydrocephalus risk is highest soon after the index event, which decreases the need for strict prolonged hospital monitoring for these patients. Unlike vasospasm in this cohort, which was clinically silent in the majority, acute hydrocephalus events were associated with worse functional outcomes. Similar to previous reports, favorable functional outcomes (mRS 0-2) at time of discharge were observed in the majority of patients with non-aneurysmal (91%) which was significantly higher than the aneurysmal group (91% vs. 40%; *P*= 0.01*)*. ### Limitations While the results of the current study are compelling, they must be interpreted within the context of the study limitations. First, our study is subject to all the limitations inherent to a retrospective analysis comprised of subjects from a single center. In addition, while the majority of our cohort (88%) had a repeat follow up DSA, under reporting underlying aneurysms in the remaining 12% who did not have a follow up DSA is a possibility. However, even with the above limitations, this is one of the largest studies available on PMSAH patients providing valuable information for clinical decision making. ## CONCLUSIONS In our cohort, “benign” PMSAH pattern was associated with a ruptured aneurysm in 6.2% of patients, and we advocate for conventional cerebral angiogram to remain part of the diagnostic workup. Expectedly, acute hydrocephalus was seen very early during the hospital course, mostly with an underlying aneurysm, and the presence of these two were associated with poorer outcomes. Vasospasm alone was not associated with unfavorable outcomes in patients with PMSAH. Our findings support less strict monitoring, and shorter hospitalization of patients with PMSAH without an underlying ruptured aneurysm or acute hydrocephalus. ## Data Availability The data referred to in the manuscript is available STROBE Statement—checklist of items that should be included in reports of observational studies ![Table4](http://medrxiv.org/) [Table4](http://medrxiv.org/content/early/2023/07/23/2023.07.17.23292803/T4) ## ACKNOWLEDGMENTS We thank and acknowledge Vickie Keller, RT(R), Thomas Frank, RT(R), Elizabeth Beno, RT(R), and William (Bill) Tajgiszer, RT(R) in imaging institute at Cleveland Clinic for their assistance in retrieving images from the imaging archives. * Received July 17, 2023. * Revision received July 17, 2023. * Accepted July 23, 2023. * © 2023, Posted by Cold Spring Harbor Laboratory The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission. ## REFERENCES 1. 1.Bederson JB, Connolly ES, Jr., Batjer HH, Dacey RG, Dion JE, Diringer MN, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40(3):994–1025. [FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjg6IjQwLzMvOTk0IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjMvMDcvMjMvMjAyMy4wNy4xNy4yMzI5MjgwMy5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 2. 2.Howard BM, Hu R, Barrow JW, Barrow DL. Comprehensive review of imaging of intracranial aneurysms and angiographically negative subarachnoid hemorrhage. Neurosurg Focus. 2019;47(6):E20. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) 3. 3.Rinkel GJ, Wijdicks EF, Vermeulen M, Ramos LM, Tanghe HL, Hasan D, et al. Nonaneurysmal perimesencephalic subarachnoid hemorrhage: CT and MR patterns that differ from aneurysmal rupture. AJNR Am J Neuroradiol. 1991;12(5):829–34. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiYWpuciI7czo1OiJyZXNpZCI7czo4OiIxMi81LzgyOSI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIzLzA3LzIzLzIwMjMuMDcuMTcuMjMyOTI4MDMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 4. 4.van Gijn J, van Dongen KJ, Vermeulen M, Hijdra A. Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology. 1985;35(4):493–7. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1212/WNL.35.4.493&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=3982634&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) 5. 5.Kapadia A, Schweizer TA, Spears J, Cusimano M, Macdonald RL. Nonaneurysmal perimesencephalic subarachnoid hemorrhage: diagnosis, pathophysiology, clinical characteristics, and long-term outcome. World Neurosurg. 2014;82(6):1131–43. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.wneu.2014.07.006&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=25003696&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) 6. 6.Mortimer AM, Appelman AP, Renowden SA. The negative predictive value of CT angiography in the setting of perimesencephalic subarachnoid hemorrhage. J Neurointerv Surg. 2016;8(7):728–31. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTE6Im5ldXJpbnRzdXJnIjtzOjU6InJlc2lkIjtzOjc6IjgvNy83MjgiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMy8wNy8yMy8yMDIzLjA3LjE3LjIzMjkyODAzLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 7. 7.Potter CA, Fink KR, Ginn AL, Haynor DR. Perimesencephalic Hemorrhage: Yield of Single versus Multiple DSA Examinations-A Single-Center Study and Meta-Analysis. Radiology. 2016;281(3):858–64. 8. 8.Elhadi AM, Zabramski JM, Almefty KK, Mendes GA, Nakaji P, McDougall CG, et al. Spontaneous subarachnoid hemorrhage of unknown origin: hospital course and long-term clinical and angiographic follow-up. J Neurosurg. 2015;122(3):663–70. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3171/2014.10.JNS14175&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=25526276&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) 9. 9.Naidech AM, Janjua N, Kreiter KT, Ostapkovich ND, Fitzsimmons BF, Parra A, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol. 2005;62(3):410–6. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/archneur.62.3.410&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=15767506&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000227446000009&link_type=ISI) 10. 10.Mensing LA, Vergouwen MDI, Laban KG, Ruigrok YM, Velthuis BK, Algra A, et al. Perimesencephalic Hemorrhage: A Review of Epidemiology, Risk Factors, Presumed Cause, Clinical Course, and Outcome. Stroke. 2018;49(6):1363–70. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjk6IjQ5LzYvMTM2MyI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIzLzA3LzIzLzIwMjMuMDcuMTcuMjMyOTI4MDMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 11. 11.Anderson CS, Feigin V, Bennett D, Lin RB, Hankey G, Jamrozik K, et al. Active and passive smoking and the risk of subarachnoid hemorrhage: an international population-based case-control study. Stroke. 2004;35(3):633–7. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjg6IjM1LzMvNjMzIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjMvMDcvMjMvMjAyMy4wNy4xNy4yMzI5MjgwMy5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 12. 12.Catapano JS, Lang MJ, Koester SW, Wang DJ, DiDomenico JD, Fredrickson VL, et al. Digital subtraction cerebral angiography after negative computed tomography angiography findings in non-traumatic subarachnoid hemorrhage. J Neurointerv Surg. 2020;12(5):526–30. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTE6Im5ldXJpbnRzdXJnIjtzOjU6InJlc2lkIjtzOjg6IjEyLzUvNTI2IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjMvMDcvMjMvMjAyMy4wNy4xNy4yMzI5MjgwMy5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 13. 13.Kalra VB, Wu X, Matouk CC, Malhotra A. Use of follow-up imaging in isolated perimesencephalic subarachnoid hemorrhage: a meta-analysis. Stroke. 2015;46(2):401–6. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjg6IjQ2LzIvNDAxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjMvMDcvMjMvMjAyMy4wNy4xNy4yMzI5MjgwMy5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 14. 14.Zhong W, Zhao P, Wang D, Li G, Sun H, Chen H, et al. Different clinical characteristics between perimesencephalic subarachnoid hemorrhage and diffuse subarachnoid hemorrhage with negative initial angiography. Turk Neurosurg. 2014;24(3):327–32. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=24848169&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) 15. 15.Delgado Almandoz JE, Jagadeesan BD, Refai D, Moran CJ, Cross DT, 3rd., Chicoine MR, et al. Diagnostic yield of repeat catheter angiography in patients with catheter and computed tomography angiography negative subarachnoid hemorrhage. Neurosurgery. 2012;70(5):1135–42. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1227/NEU.0b013e318242575e&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=22105208&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000303390400029&link_type=ISI) 16. 16.Moscovici S, Fraifeld S, Ramirez-de-Noriega F, Rosenthal G, Leker RR, Itshayek E, et al. Clinical relevance of negative initial angiogram in spontaneous subarachnoid hemorrhage. Neurol Res. 2013;35(2):117–22. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1179/1743132812Y.0000000147&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=23452573&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) 17. 17.Cruz JP, Sarma D, Noel de Tilly L. Perimesencephalic subarachnoid hemorrhage: when to stop imaging? Emerg Radiol. 2011;18(3):197–202. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s10140-011-0939-6&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=21360167&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) 18. 18.Agid R, Andersson T, Almqvist H, Willinsky RA, Lee SK, terBrugge KG, et al. Negative CT angiography findings in patients with spontaneous subarachnoid hemorrhage: When is digital subtraction angiography still needed? AJNR Am J Neuroradiol. 2010;31(4):696–705. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiYWpuciI7czo1OiJyZXNpZCI7czo4OiIzMS80LzY5NiI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIzLzA3LzIzLzIwMjMuMDcuMTcuMjMyOTI4MDMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 19. 19.Little AS, Garrett M, Germain R, Farhataziz N, Albuquerque FC, McDougall CG, et al. Evaluation of patients with spontaneous subarachnoid hemorrhage and negative angiography. Neurosurgery. 2007;61(6):1139–50; discussion 50-1. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1227/01.neu.0000306091.30517.e7&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=18162892&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000252044400012&link_type=ISI) 20. 20.Westerlaan HE, Gravendeel J, Fiore D, Metzemaekers JD, Groen RJ, Mooij JJ, et al. Multislice CT angiography in the selection of patients with ruptured intracranial aneurysms suitable for clipping or coiling. Neuroradiology. 2007;49(12):997–1007. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s00234-007-0293-2&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17891387&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000251098400004&link_type=ISI) 21. 21.Kershenovich A, Rappaport ZH, Maimon S. Brain computed tomography angiographic scans as the sole diagnostic examination for excluding aneurysms in patients with perimesencephalic subarachnoid hemorrhage. Neurosurgery. 2006;59(4):798–801; discussion -2. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1227/01.NEU.0000232724.19888.C6&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=16915122&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) 22. 22.Alen JF, Lagares A, Lobato RD, Gomez PA, Rivas JJ, Ramos A. Comparison between perimesencephalic nonaneurysmal subarachnoid hemorrhage and subarachnoid hemorrhage caused by posterior circulation aneurysms. J Neurosurg. 2003;98(3):529–35. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3171/jns.2003.98.3.0529&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=12650424&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000181460900012&link_type=ISI) 23. 23.van Dijk EJ, Hupperts RM, van der Jagt M, Bijvoet HW, Hasan D. Diagnosis of perimesencephalic nonaneurysmal subarachnoid hemorrhage with computed tomography. J Stroke Cerebrovasc Dis. 2001;10(6):247–51. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17903834&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) 24. 24.Velthuis BK, Van Leeuwen MS, Witkamp TD, Ramos LM, Berkelbach van Der Sprenkel JW, Rinkel GJ. Computerized tomography angiography in patients with subarachnoid hemorrhage: from aneurysm detection to treatment without conventional angiography. J Neurosurg. 1999;91(5):761–7. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3171/jns.1999.91.5.0761&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=10541232&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F07%2F23%2F2023.07.17.23292803.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000083251800006&link_type=ISI)